Emmanuelle Charpentier

Microbiologist Leader
Gene Editing Pioneer
Nobel Prize Winner
50K Followers
5M Net Worth
Max Planck Institute, University of California, Berkeley Brands

Brands Emmanuelle Charpentier talks about

ERS Genomics
Emmanuelle Charpentier
5 months ago 1 view
A
Answer ERS Genomics
Emmanuelle Charpentier co-founded ERS Genomics to develop and license the core intellectual property of the CRISPR-Cas9 technology for various biotechnology and biomedical applications.